FI66383C - Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat - Google Patents
Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat Download PDFInfo
- Publication number
- FI66383C FI66383C FI783126A FI783126A FI66383C FI 66383 C FI66383 C FI 66383C FI 783126 A FI783126 A FI 783126A FI 783126 A FI783126 A FI 783126A FI 66383 C FI66383 C FI 66383C
- Authority
- FI
- Finland
- Prior art keywords
- methyl
- compound
- propyl
- pyrimidinedione
- hydroxypropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7711581A SE416810C (sv) | 1977-10-14 | 1977-10-14 | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7711581 | 1977-10-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI783126A FI783126A (fi) | 1979-04-15 |
| FI66383B FI66383B (fi) | 1984-06-29 |
| FI66383C true FI66383C (fi) | 1984-10-10 |
Family
ID=20332576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI783126A FI66383C (fi) | 1977-10-14 | 1978-10-13 | Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4233303A (hu) |
| EP (1) | EP0001735B1 (hu) |
| JP (1) | JPS5479296A (hu) |
| AT (1) | AT363491B (hu) |
| AU (1) | AU521585B2 (hu) |
| CA (1) | CA1109470A (hu) |
| CS (1) | CS208756B2 (hu) |
| DD (1) | DD139855A5 (hu) |
| DE (1) | DE2862017D1 (hu) |
| DK (1) | DK148260C (hu) |
| FI (1) | FI66383C (hu) |
| HK (1) | HK6385A (hu) |
| HU (1) | HU180219B (hu) |
| IE (1) | IE47884B1 (hu) |
| IT (1) | IT1109208B (hu) |
| NO (1) | NO147562C (hu) |
| NZ (1) | NZ188566A (hu) |
| SE (1) | SE416810C (hu) |
| SG (1) | SG85584G (hu) |
| SU (1) | SU755199A3 (hu) |
| ZA (1) | ZA785335B (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| SE8002910L (sv) * | 1980-04-18 | 1981-10-19 | Draco Ab | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
| US4755517A (en) * | 1986-07-31 | 1988-07-05 | Warner-Lambert Company | Derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| US5321029A (en) * | 1988-11-14 | 1994-06-14 | Beecham-Wuelfing Gmbh & Co.K.G. | Xanthines |
| GB8826595D0 (en) * | 1988-11-14 | 1988-12-21 | Beecham Wuelfing Gmbh & Co Kg | Active compounds |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| GB8929208D0 (en) * | 1989-12-27 | 1990-02-28 | Almirall Lab | New xanthine derivatives |
| US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
| US5342841A (en) * | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| US5395836A (en) * | 1993-04-07 | 1995-03-07 | Kyowa Hakko Kogyo Co., Ltd. | 8-tricycloalkyl xanthine derivatives |
| GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
| US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| US5661153A (en) * | 1994-07-19 | 1997-08-26 | Japan Energy Corporation | 1-arylpyrimidine derivatives and pharmaceutical use thereof |
| ATE247655T1 (de) * | 1994-12-13 | 2003-09-15 | Euro Celtique Sa | Dreifachsubstituierte thioxanthine |
| WO1996018399A1 (en) * | 1994-12-13 | 1996-06-20 | Euro-Celtique, S.A. | Aryl thioxanthines |
| US6166041A (en) * | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
| US6075016A (en) * | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
| US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
| BRPI0409699A (pt) | 2003-04-25 | 2006-04-18 | Novacardia Inc | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos |
| BRPI0509753A (pt) * | 2004-04-16 | 2007-10-16 | Novacardia Inc | composição farmacêutica e método de tratamento de doença cardiovascular |
| US20070049757A1 (en) * | 2005-08-26 | 2007-03-01 | Rieger Jayson M | Methods for the synthesis of substituted amino uracils |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1911279A1 (de) * | 1969-03-05 | 1970-11-12 | Eckert Dr Theodor | Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen |
| US3900474A (en) * | 1973-05-14 | 1975-08-19 | Kendall & Co | Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines |
| US4061753A (en) * | 1976-02-06 | 1977-12-06 | Interx Research Corporation | Treating psoriasis with transient pro-drug forms of xanthine derivatives |
| US4120947A (en) * | 1976-03-31 | 1978-10-17 | Cooper Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| CA1077932A (en) | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
-
1977
- 1977-10-14 SE SE7711581A patent/SE416810C/sv unknown
-
1978
- 1978-09-19 ZA ZA00785335A patent/ZA785335B/xx unknown
- 1978-09-29 US US05/947,002 patent/US4233303A/en not_active Expired - Lifetime
- 1978-10-03 AU AU40365/78A patent/AU521585B2/en not_active Expired
- 1978-10-03 NZ NZ188566A patent/NZ188566A/en unknown
- 1978-10-03 DE DE7878850015T patent/DE2862017D1/de not_active Expired
- 1978-10-03 EP EP78850015A patent/EP0001735B1/en not_active Expired
- 1978-10-04 AT AT0714478A patent/AT363491B/de not_active IP Right Cessation
- 1978-10-10 CA CA313,026A patent/CA1109470A/en not_active Expired
- 1978-10-12 DK DK453778A patent/DK148260C/da not_active IP Right Cessation
- 1978-10-12 DD DD78208423A patent/DD139855A5/de unknown
- 1978-10-13 IE IE2041/78A patent/IE47884B1/en unknown
- 1978-10-13 NO NO783471A patent/NO147562C/no unknown
- 1978-10-13 IT IT51499/78A patent/IT1109208B/it active
- 1978-10-13 HU HU78DA359A patent/HU180219B/hu unknown
- 1978-10-13 SU SU782675299A patent/SU755199A3/ru active
- 1978-10-13 CS CS786669A patent/CS208756B2/cs unknown
- 1978-10-13 FI FI783126A patent/FI66383C/fi not_active IP Right Cessation
- 1978-10-14 JP JP12573978A patent/JPS5479296A/ja active Pending
-
1984
- 1984-11-29 SG SG855/84A patent/SG85584G/en unknown
-
1985
- 1985-01-24 HK HK63/85A patent/HK6385A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO783471L (no) | 1979-04-18 |
| IE782041L (en) | 1979-04-14 |
| IT1109208B (it) | 1985-12-16 |
| CS208756B2 (en) | 1981-09-15 |
| HK6385A (en) | 1985-02-01 |
| NO147562C (no) | 1983-05-18 |
| SU755199A3 (en) | 1980-08-07 |
| SE416810C (sv) | 1982-07-19 |
| IE47884B1 (en) | 1984-07-11 |
| EP0001735B1 (en) | 1982-09-01 |
| CA1109470A (en) | 1981-09-22 |
| DK453778A (da) | 1979-04-15 |
| ATA714478A (de) | 1980-09-15 |
| EP0001735A1 (en) | 1979-05-02 |
| AU521585B2 (en) | 1982-04-22 |
| DK148260C (da) | 1986-02-10 |
| JPS5479296A (en) | 1979-06-25 |
| DE2862017D1 (en) | 1982-10-28 |
| IT7851499A0 (it) | 1978-10-13 |
| HU180219B (en) | 1983-02-28 |
| DD139855A5 (de) | 1980-01-23 |
| ZA785335B (en) | 1979-09-26 |
| FI783126A (fi) | 1979-04-15 |
| DK148260B (da) | 1985-05-20 |
| SG85584G (en) | 1985-06-07 |
| FI66383B (fi) | 1984-06-29 |
| SE416810B (sv) | 1981-02-09 |
| AU4036578A (en) | 1980-04-17 |
| NZ188566A (en) | 1984-07-06 |
| US4233303A (en) | 1980-11-11 |
| SE7711581L (sv) | 1979-04-15 |
| AT363491B (de) | 1981-08-10 |
| NO147562B (no) | 1983-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI66383C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat | |
| TWI335918B (en) | Novel thioxanthine derivatives and medical use thereof | |
| EP0011609B1 (en) | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease | |
| EP0916673B1 (en) | 6-Amino purine derivatives having PDE-IV inhibition activity | |
| EP0010531B1 (en) | 3-alkylxanthines, processes for their preparation and compositions for use in the treatment of chronic obstructive airway disease and cardiac disease | |
| CZ391891A3 (en) | Xanthine derivatives,process of their preparation and pharmaceutical preparation containing them | |
| FI69465B (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner | |
| CS262690B2 (en) | Process for preparing 1-/hydroxystyryl/-5h-2,3-benzodiazepines | |
| US20060148832A1 (en) | Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents | |
| JPS6222771A (ja) | ５−置換−６−アミノピリミジン誘導体、組成物および使用 | |
| JP2991806B2 (ja) | ３‐（メルカプトアルキル）‐キナゾリン‐２，４（１ｈ，３ｈ）‐ジオン、その製造方法および製薬調合物 | |
| US20230045031A1 (en) | Diarylamide Compound and Application Thereof | |
| CZ292205B6 (cs) | Deriváty xanthinu k přípravě léčiva k léčení a profylaxi šokových onemocnění, nové deriváty xanthinu a způsob jejich přípravy | |
| JPH02295977A (ja) | フェニルピリミドン誘導体 | |
| CN101314603B (zh) | 缬氨酸保护的咪唑并［1,2-a］嘌呤三环碱基开环核苷类化合物、其制备方法和用途 | |
| JPH03294277A (ja) | ピペリジン誘導体 | |
| JPH05262770A (ja) | 化学的製法 | |
| CN117924252A (zh) | 一种喹唑啉-咔唑骨架衍生物及其抗糖尿病活性 | |
| JP2603488B2 (ja) | 新規なエラグ酸硫酸エステル誘導体，その製法及び用途 | |
| JPS6153271A (ja) | ローダニン誘導体 | |
| JPH04128285A (ja) | キサンチン誘導体 | |
| FR2498602A1 (fr) | Nouveaux derives therapeutiquement utiles de la xanthine, procede de preparation et compositions pharmaceutiques les contenant | |
| JPS61172880A (ja) | ２−アミノ−５−オキソ−５Ｈ−〔１〕ベンゾピラノ〔２，３−ｂ〕ピリジン−３−カルボン酸誘導体およびその製造法 | |
| JPS6212764A (ja) | ジヒドロピリダジノン誘導体 | |
| JPH03127733A (ja) | ベンゾイソオキサゾリン―３―オン誘導体を含有する抗うつ剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: AKTIEBOLAGET DRACO |